Boston Scientific plan to buy AMS pelvic device unit from Endo Pharma for $2 billion.

Boston Scientific Corp is close to buying Endo International PLC's AMS medical device unit, a deal that could value the business at around $2 billion, The companies are aiming to finalize an agreement within a matter of weeks, the people said this week, cautioning that discussions are continuing and could still fail to proceed. Based in Minnetonka, Minnesota, Endo's AMS unit supplies devices to treat pelvic disorders.